Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 July 2007, Vol. 110, No. 2, pp. 695-708.
Prepublished online as a Blood First Edition Paper on March 27, 2007; DOI 10.1182/blood-2006-11-051672.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow All Versions of this Article:
blood-2006-11-051672v1
110/2/695    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morton, L. M
Right arrow Articles by Weisenburger, D. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morton, L. M
Right arrow Articles by Weisenburger, D. D
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted November 2, 2006
Accepted March 10, 2007

Proposed classification of lymphoid neoplasms for epidemiologic research from the International Lymphoma Epidemiology Consortium (InterLymph)

Lindsay M Morton*, Jennifer J Turner, James R Cerhan, Martha S Linet, Patrick A Treseler, Christina A Clarke, Andrew Jack, Wendy Cozen, Marc Maynadie, John J Spinelli, Adele Seniori Costantini, Thomas Rudiger, Aldo Scarpa, Tongzhang Zheng, and Dennis D Weisenburger

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, MD, United States
Department of Anatomical Pathology, St. Vincent's Hospital, New South Wales, Australia
Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, United States
Department of Pathology, University of California at San Francisco, San Francisco, CA, United States
Northern California Cancer Center, Fremont, CA, United States
Haematological Malignancy Diagnostic Service, Department of Haematology, Leeds Teaching Hospital, NHS Trust, Leeds, United Kingdom
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
Haematology Laboratory, University Hospital, Dijon, France
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Occupational and Environmental Epidemiology Unit, Center for Study and Prevention of Cancer, Scientific Institute of Tuscany, Florence, Italy
Institute of Pathology, University of Wurzburg, Wurzburg, Germany
Department of Pathology, University of Verona, Ospedale Policlinico, Verona, Italy
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, United States
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, United States

* Corresponding author; email: mortonli{at}mail.nih.gov.

Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathological schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases-Oncology, third edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will likely prove to be critical for elucidating etiologies of the various lymphoid neoplasms.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Kanda, K. Matsuo, T. Kawase, T. Suzuki, T. Ichinohe, M. Seto, Y. Morishima, K. Tajima, and H. Tanaka
Association of Alcohol Intake and Smoking with Malignant Lymphoma Risk in Japanese: A Hospital-Based Case-Control Study at Aichi Cancer Center
Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2436 - 2441.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. Vajdic, M. O. Falster, S. de Sanjose, O. Martinez-Maza, N. Becker, P. M. Bracci, M. Melbye, K. E. Smedby, E. A. Engels, J. Turner, et al.
Atopic Disease and Risk of Non-Hodgkin Lymphoma: An InterLymph Pooled Analysis
Cancer Res., August 15, 2009; 69(16): 6482 - 6489.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Q. Lan, L. M. Morton, B. Armstrong, P. Hartge, I. Menashe, T. Zheng, M. P. Purdue, J. R. Cerhan, Y. Zhang, A. Grulich, et al.
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies
Blood, July 9, 2009; 114(2): 264 - 267.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. H.M. Keegan, L. A. McClure, J. M. Foran, and C. A. Clarke
Improvements in Survival After Follicular Lymphoma by Race/Ethnicity and Socioeconomic Status: A Population-Based Study
J. Clin. Oncol., June 20, 2009; 27(18): 3044 - 3051.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. T. Bradford, S. S. Devesa, W. F. Anderson, and J. R. Toro
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
Blood, May 21, 2009; 113(21): 5064 - 5073.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
L. R. Goldin, M. Bjorkholm, S. Y. Kristinsson, I. Turesson, and O. Landgren
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia
Haematologica, May 1, 2009; 94(5): 647 - 653.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. M. Morton, M. P. Purdue, T. Zheng, S. S. Wang, B. Armstrong, Y. Zhang, I. Menashe, N. Chatterjee, S. Davis, Q. Lan, et al.
Risk of Non-Hodgkin Lymphoma Associated with Germline Variation in Genes that Regulate the Cell Cycle, Apoptosis, and Lymphocyte Development
Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1259 - 1270.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. P. Purdue, Q. Lan, S. S. Wang, A. Kricker, I. Menashe, T.-Z. Zheng, P. Hartge, A. E. Grulich, Y. Zhang, L. M. Morton, et al.
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma
Carcinogenesis, February 1, 2009; 30(2): 275 - 281.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. M. Morton, S. S. Wang, W. Cozen, M. S. Linet, N. Chatterjee, S. Davis, R. K. Severson, J. S. Colt, M. A. Vasef, N. Rothman, et al.
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes
Blood, December 15, 2008; 112(13): 5150 - 5160.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
K. L. Edlefsen, A. De Roos, and A. LaCroix
Application of the InterLymph Consortium's Proposed Classification of Lymphoid Neoplasms for Epidemiologic Research to a Large, Nationwide Health Study: Experience in the Women's Health Initiative
Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 4669 - 4669.
[Abstract]


Home page
BloodHome page
Q. Lan, U. Lim, C.-S. Liu, S. J. Weinstein, S. Chanock, M. R. Bonner, J. Virtamo, D. Albanes, and N. Rothman
A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma
Blood, November 15, 2008; 112(10): 4247 - 4249.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. M. Evens and B. C.-H. Chiu
The Challenges of Epidemiologic Research in Non-Hodgkin Lymphoma
JAMA, November 5, 2008; 300(17): 2059 - 2061.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. A. Anderson, R. Pfeiffer, J. L. Warren, O. Landgren, S. Gadalla, S. I. Berndt, W. Ricker, R. Parsons, W. Wheeler, and E. A. Engels
Hematopoietic Malignancies Associated with Viral and Alcoholic Hepatitis
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3069 - 3075.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. M. Habermann, S. S. Wang, M. J. Maurer, L. M. Morton, C. F. Lynch, S. M. Ansell, P. Hartge, R. K. Severson, N. Rothman, S. Davis, et al.
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era
Blood, October 1, 2008; 112(7): 2694 - 2702.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. E. Khan, V. Gallo, J. Linseisen, R. Kaaks, S. Rohrmann, O. Raaschou-Nielsen, A. Tjonneland, H. E. Johnsen, K. Overvad, M. M. Bergmann, et al.
Diabetes and the risk of non-Hodgkin's lymphoma and multiple myeloma in the European Prospective Investigation into Cancer and Nutrition
Haematologica, June 1, 2008; 93(6): 842 - 850.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
Y. Zhang, S. D. Sanjose, P. M. Bracci, L. M. Morton, R. Wang, P. Brennan, P. Hartge, P. Boffetta, N. Becker, M. Maynadie, et al.
Personal Use of Hair Dye and the Risk of Certain Subtypes of Non-Hodgkin Lymphoma
Am. J. Epidemiol., June 1, 2008; 167(11): 1321 - 1331.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Ekstrom Smedby, C. M. Vajdic, M. Falster, E. A. Engels, O. Martinez-Maza, J. Turner, H. Hjalgrim, P. Vineis, A. Seniori Costantini, P. M. Bracci, et al.
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
Blood, April 15, 2008; 111(8): 4029 - 4038.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Maskarinec, E. Erber, J. Gill, W. Cozen, and L. N. Kolonel
Overweight and Obesity at Different Times in Life as Risk Factors for Non-Hodgkin's Lymphoma: The Multiethnic Cohort
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 196 - 203.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020